Immunicom

Immunicom is a biotechnology company. We focus on creating novel immunotherapies based on our breakthrough technology platform, Immunopheresis™.Immunopheresis aims to address unmet medical needs in cancer, inflammation, cardiovascular, renal, and autoimmune diseases and is accessible to a broad patient population.